| 臺大學術典藏 |
2021-01-05T03:34:31Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Li C.-C.; Kuo Y.-Y.; Chen C.-Y.; Tang J.-L.; Tsai C.-H.; Hou H.-A.; Tien F.-M.; Lin C.-T.; MING YAO; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T03:34:30Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien H.-F.; Chou W.-C.; MING YAO; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Wu S.-J.; Lin C.-T.; Lin L.-I.; Liao X.-W.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Peng Y.-L.; Tien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:28Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Huang S.-Y.; Hou H.-A.; Chou W.-C.; Tsai C.-H.; Lin C.-T.; Li C.-C.; MING YAO; Chen C.-H.; Liao X.-W.; Liu J.-H.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-05T03:34:27Z |
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
|
Huang T.-C.; Tang J.-L.; MING YAO; Yang Y.-T.; Ko B.-S.; Yu S.-C.; Wang Y.-H. |
| 臺大學術典藏 |
2021-01-05T02:30:56Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Tien H.-F.; Tsay W.; Lu H.-Y.; Ko B.-S.; Huang S.-Y.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Hou H.-A.; Chou W.-C.; SHENG-CHIEH CHOU; Hsu S.-C. |
| 臺大學術典藏 |
2021-01-05T02:30:56Z |
Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations
|
Tien H.-F.; Chen Y.-C.; Tsay W.; Huang S.-Y.; Ko B.-S.; Yao M.; Chen C.-Y.; SHENG-CHIEH CHOU; Tang J.-L.; Hou H.-A.; Chou W.-C.; Hu F.-C. |
| 臺大學術典藏 |
2021-01-05T02:30:55Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Lin C.-T.; Li C.-C.; Yao M.; Chen C.-Y.; Tsai C.-H.; Kuo Y.-Y.; Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Liu C.-W.; Liu M.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; SHENG-CHIEH CHOU; Tsay W.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-05T02:30:55Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Liu C.-Y.; Kuo S.-H.; Tsai C.-H.; Chiang Y.; Liu M.-C.; Chang H.-H.; Yang Y.-L.; Lu M.-Y.; Chou H.-T.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Hsu S.-C.; Wu S.-J.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; Liu J.-H.; Lin C.-C.; Chen Y.-H.; Liao X.-W.; Wu J.-K.; SHENG-CHIEH CHOU; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Ko B.-S.; Tsay W.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan
|
SHANG-JU WU; Tien H.-F.; Wang C.-H.; Chen C.-Y.; Su I.-J.; Tang J.-L.; Chou W.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:40Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Ko B.-S.; Huang S.-Y.; Yao M.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:39Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Lee F.-Y.; Kuo K.-T.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Liu M.-C.; Liu C.-W.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Kuo K.-T.; Lee F.-Y.; Liu M.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Lin C.-W.; Jhuang J.-Y.; Hou H.-A.; Cheng C.-L.; Tien H.-F.; Chen Y.-C.; Tsay W.; Chen C.-Y.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Huang S.-Y.; Yao M.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; SHANG-JU WU; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Ko B.-S.; Tang J.-L.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Kuo Y.-Y.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
|
Chen H.-Y.; Lin C.-W.; Lai Y.-J.; Jhuang J.-Y.; Liu C.-Y.; Lee M.-C.; Cheng C.-L.; Hou H.-A.; Tien H.-F.; Liu F.-T.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W. |
| 臺大學術典藏 |
2021-01-05T00:56:36Z |
Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence - Clinical implication and comparison between the West and the East
|
Huang S.-Y.; Lin C.-T.; SHANG-JU WU; Tien H.-F.; Tsay W.; Tang J.-L.; Lee F.-Y.; Liu M.-C.; Hou H.-A.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Yao M. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Tsay W.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Tseng M.-H.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; SHANG-JU WU; Liu C.-Y.; Chen C.-Y.; Tsay W.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Yang Y.-T.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Kuo Y.-Y.; Li C.-C.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Hsu S.-C.; Lin C.-T.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:34Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Chen C.-Y.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tien H.-F.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Lee M.-C.; Lai Y.-J.; Jhuang J.-Y.; Tang J.-L.; Hou H.-A.; Chen Y.-K.; Tien H.-F.; Chen Y.-C.; Tsay W.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Liu C.-Y.; Chen C.-Y.; Lin C.-C.; Lai Y.-J.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:32Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Tseng M.-H.; Lin L.-I.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; SHANG-JU WU; Lin C.-T.; Chen C.-Y.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:32Z |
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan
|
SHANG-JU WU; Tang J.-L.; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Tien H.-F.; Hou H.-A.; Chou W.-C.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Chen Y.-C.; Chang S.-C.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Chen C.-Y.; Liu C.-Y.; Lin C.-C.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Chiang Y.-C.; Tseng M.-H.; Chou W.-C.; Lin C.-C.; Lin T.-Y.; Yao C.-Y.; Hou H.-A.; Li C.-C.; Hsu S.-C.; Chen C.-Y.; Ko B.-S.; Lin C.-T.; Liao X.-W.; SHANG-JU WU; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:28Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Ko B.-S.; Huang S.-Y.; Li C.-C.; Tsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Hsu S.-C.; Lin C.-T.; SHANG-JU WU; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:26Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tseng M.-H.; Kuo Y.-Y.; Chen C.-Y.; Chiu Y.-C.; Tien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Liao X.-W.; Lin L.-I.; Lin C.-T.; SHANG-JU WU; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:26Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tang J.-L.; Hou H.-A.; Tsai C.-H.; Tien F.-M.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W. |
| 臺大學術典藏 |
2021-01-05T00:56:25Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Chou S.-C.; Liu J.-H.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan
|
Tang J.-L.; Ko B.-S.; Tsai W.; Chen Y.-C.; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:03Z |
Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan
|
Ko B.-S.; Tang J.-L.; Lee F.-Y.; Liu M.-C.; Tsai W.; Chen Y.-C.; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:57Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
HWEI-FANG TIEN; Lin K.-H.; Lin D.-T.; Chen Y.-C.; Ko B.-S.; Yao M.; Chiou R.-J.; Huang C.-F.; Yeh Y.-C.; Chang H.-H.; Tsay W.; Lin L.-I.; Tang J.-L.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Huang S.-Y.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Tang J.-L.; Yao M.; Wu S.-J.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:53Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Chen Y.-C.; Yao M.; Huang S.-Y.; Tsay W.; Chen C.-Y.; Tang J.-L.; Hsu C.; Huang T.-C.; Ko B.-S.; HWEI-FANG TIEN; Shen M.-C.; Wang C.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:51Z |
HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia
|
Chen Y.-C.; HWEI-FANG TIEN; Tang J.-L.; Ko B.-S.; Yao M.; Wu S.-J. |
| 臺大學術典藏 |
2021-01-04T12:12:51Z |
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
|
Chen Y.-K.; Tang J.-L.; Yao M.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; HWEI-FANG TIEN; Chang H.-H.; Lu M.-Y.; Lin T.-T.; Lin K.-H.; Hsiao C.-H.; Lin C.-W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:44Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Chen C.-Y.; Lin C.-W.; Jhuang J.-Y.; Cheng C.-L.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:42Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Hou H.-A.; Li Y.; Kuo Y.-Y.; Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Ko B.-S.; Yao M.; Huang S.-Y.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:39Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:37Z |
Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement
|
Chiou T.-J.; Chen T.Y.; Chang C.-S.; Chang M.-C.; Ko B.-S.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; Tang J.-L.; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:35Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Chou W.-C.; Lin C.-C.; Hou H.-A.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:31Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Lin H.-H.; Huang S.-Y.; Tsay W.; Lu H.-Y.; Ko B.-S.; Hsu S.-C.; Chou W.-C.; Chou S.-C.; Hou H.-A.; Wu S.-J.; Yao M.; Tang J.-L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:30Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Kuo Y.-Y.; Hou H.-A.; Liu C.-Y.; Huang S.Y.; Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Chiang Y.-C.; Liu M.-C.; Tseng M.-H.; Lin L.-I.; Lin C.-C.; Tsai C.-H.; Chou W.-C.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:28Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tang J.-L.; Liu C.-Y.; Hou H.-A.; Tsai C.-H.; HWEI-FANG TIEN; Wu S.-J.; Lin C.-T.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:23Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; Ko B.-S.; Huang S.-Y.; Li C.-C.; Tang J.-L.; Yao M.; Chen C.-Y.; Chou W.-C.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Kuo Y.-Y.; Wu S.-J.; Hou H.-A.; Tsai C.-H.; Hsu S.-C.; Lin C.-T.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:22Z |
2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan
|
Vaccines; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; Marrow Transplantation, Medical Foundation in Memory of Dr Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Ko B.-S.; Chen W.-T.; Kung H.-C.; Wu U.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; HWEI-FANG TIEN; Chang S.-C.; Chuang Y.-C.; Lin D.-T.; The Infectious Diseases Society of Taiwan, The Hematology Society of Taiwan, The Taiwan Society of Blood |
